1. Home
  2. CTMX vs HZO Comparison

CTMX vs HZO Comparison

Compare CTMX & HZO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • HZO
  • Stock Information
  • Founded
  • CTMX 2008
  • HZO 1998
  • Country
  • CTMX United States
  • HZO United States
  • Employees
  • CTMX N/A
  • HZO N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • HZO Auto & Home Supply Stores
  • Sector
  • CTMX Health Care
  • HZO Consumer Discretionary
  • Exchange
  • CTMX Nasdaq
  • HZO Nasdaq
  • Market Cap
  • CTMX 444.3M
  • HZO 450.3M
  • IPO Year
  • CTMX 2015
  • HZO 1998
  • Fundamental
  • Price
  • CTMX $2.48
  • HZO $27.71
  • Analyst Decision
  • CTMX Strong Buy
  • HZO Strong Buy
  • Analyst Count
  • CTMX 2
  • HZO 6
  • Target Price
  • CTMX $5.00
  • HZO $36.50
  • AVG Volume (30 Days)
  • CTMX 2.7M
  • HZO 334.7K
  • Earning Date
  • CTMX 08-07-2025
  • HZO 07-24-2025
  • Dividend Yield
  • CTMX N/A
  • HZO N/A
  • EPS Growth
  • CTMX 128.27
  • HZO N/A
  • EPS
  • CTMX 0.49
  • HZO 2.44
  • Revenue
  • CTMX $147,557,000.00
  • HZO $2,420,818,000.00
  • Revenue This Year
  • CTMX N/A
  • HZO $0.21
  • Revenue Next Year
  • CTMX N/A
  • HZO $3.78
  • P/E Ratio
  • CTMX $5.11
  • HZO $11.26
  • Revenue Growth
  • CTMX 23.81
  • HZO N/A
  • 52 Week Low
  • CTMX $0.40
  • HZO $16.85
  • 52 Week High
  • CTMX $3.10
  • HZO $38.20
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 56.59
  • HZO 67.67
  • Support Level
  • CTMX $2.15
  • HZO $24.90
  • Resistance Level
  • CTMX $2.44
  • HZO $26.36
  • Average True Range (ATR)
  • CTMX 0.24
  • HZO 1.08
  • MACD
  • CTMX -0.05
  • HZO 0.16
  • Stochastic Oscillator
  • CTMX 39.71
  • HZO 99.68

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About HZO MarineMax Inc. (FL)

MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S.

Share on Social Networks: